Paul Hassoun

Director, Pulmonary Hypertension Program · Johns Hopkins University School of Medicine

Credentials: · · · · · ·

History

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology
Review · Journal of the American College of Cardiology · 2013 · Last of 13 authors · 822 citations
Tricuspid annular displacement predicts survival in pulmonary hypertension
American Journal of Respiratory and Critical Care Medicine · 2006 · Last of 12 authors · 814 citations
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension
American Journal of Respiratory and Critical Care Medicine · 2009 · Last of 8 authors · 763 citations

Mechanisms of Right Ventricular Dysfunction in Scleroderma-Associated PAH
National Heart, Lung, and Blood Institute · R01
Contact PI · $6.2M · Johns Hopkins University
2012–2026
Functional Impact of Col18a1/Endostatin Variants in PAH
National Heart, Lung, and Blood Institute · R01
PI · $2.5M · Johns Hopkins University
2017–2021
Hopkins Clinical Center for Pulmonary Vascular Disease Phenomics Program
National Heart, Lung, and Blood Institute · U01
Contact PI · $1.1M · Johns Hopkins University
2014–2021
Prognostic Role of Plasma Xanthine Oxidoreductase in ARDS Patients
National Heart, Lung, and Blood Institute · R21
Contact PI · $245.6K · Johns Hopkins University
2018–2021

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
Principal investigator · Completed
Johns Hopkins University
2019–2025
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Principal investigator · Completed · Phase 4
Johns Hopkins University
2010–2014
Pulmonary Hypertension Association Registry
Site PI · Recruiting
Pulmonary Hypertension Association, Inc.
2015–2025